Elanco Animal Health Retained Earnings (Accumulated Deficit) 2016-2024 | ELAN

Elanco Animal Health retained earnings (accumulated deficit) from 2016 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Elanco Animal Health retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-2.306B, a 119.41% increase year-over-year.
  • Elanco Animal Health retained earnings (accumulated deficit) for 2023 were $-2.288B, a 116.46% increase from 2022.
  • Elanco Animal Health retained earnings (accumulated deficit) for 2022 were $-1.057B, a 7.97% increase from 2021.
  • Elanco Animal Health retained earnings (accumulated deficit) for 2021 were $-0.979B, a 105.24% increase from 2020.
Elanco Animal Health Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-2,288
2022 $-1,057
2021 $-979
2020 $-477
2019 $84
2018 $16
2017 $
2016 $
2015 $
Elanco Animal Health Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-2,306
2024-03-31 $-2,256
2023-12-31 $-2,288
2023-09-30 $-2,147
2023-06-30 $-1,051
2023-03-31 $-954
2022-12-31 $-1,057
2022-09-30 $-972
2022-06-30 $-923
2022-03-31 $-901
2021-12-31 $-979
2021-09-30 $-852
2021-06-30 $-748
2021-03-31 $-538
2020-12-31 $-477
2020-09-30 $-154
2020-06-30 $-19
2020-03-31 $34
2019-12-31 $84
2019-09-30 $94
2019-06-30 $84
2019-03-31 $48
2018-12-31 $16
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.242B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00